LCG
BLFS icon

Lisanti Capital Growth’s BioLife Solutions BLFS Stock Holding History

Lisanti Capital Growth’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-66,782
Closed -$1.67M – 115
2024
Q3 		$1.67M Sell
66,782
-8,095
-11% -$191K 0.42% 90
2024
Q2 		$1.6M Buy
+74,877
New +$1.45M 0.39% 87
2021
Q4 		– Sell
-104,958
Closed -$4.44M – 120
2021
Q3 		$4.44M Buy
+104,958
New +$5.05M 0.65% 64
2021
Q1 		– Sell
-57,670
Closed -$2.3M – 136
2020
Q4 		$2.3M Buy
+57,670
New +$1.97M 0.32% 96

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lisanti Capital Growth's BLFS Position: Q4 2024 in Review

Lisanti Capital Growth sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 66,782 shares — an estimated $1.67M sold.

Lisanti Capital Growth first reported a position in BLFS in Q4 2020 and held it in 4 quarters. The position peaked at $4.44M in Q3 2021. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

  • Lisanti Capital Growth reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 66,782 BioLife Solutions shares in Q4 2024, an estimated $1.67M.
  • Lisanti Capital Growth first reported a position in BioLife Solutions in Q4 2020 and held it in 4 quarters.
  • Lisanti Capital Growth's BioLife Solutions position peaked at $4.44M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Lisanti Capital Growth's 13F filing for Q4 2024, filed 7 Feb 2025.